These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32602126)

  • 1. Teriparatide (recombinant human parathyroid hormone 1-34) therapy in myeloma patients with severe osteoporosis and fractures despite effective anti-myeloma therapy and bisphosphonates: A pilot study.
    Diamond TH; Golombick T; Manoharan A; Ramakrishna R; Bryant C
    Am J Hematol; 2020 Oct; 95(10):E272-E276. PubMed ID: 32602126
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of osteoporosis with parathyroid hormone and teriparatide.
    Pleiner-Duxneuner J; Zwettler E; Paschalis E; Roschger P; Nell-Duxneuner V; Klaushofer K
    Calcif Tissue Int; 2009 Mar; 84(3):159-70. PubMed ID: 19189037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
    Brixen KT; Christensen PM; Ejersted C; Langdahl BL
    Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Teriparatide: an anabolic drug for the treatment of patients with osteoporosis].
    Lems WF; Hamdy NA; Netelenbos JC
    Ned Tijdschr Geneeskd; 2006 Jan; 150(3):132-7. PubMed ID: 16463613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment with recombinant parathyroid hormone of advanced osteoporosis--series of cases].
    Skiba K; Adamczak M; Wiecek A
    Przegl Lek; 2011; 68(7):391-5. PubMed ID: 22010479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.
    Hodsman AB; Bauer DC; Dempster DW; Dian L; Hanley DA; Harris ST; Kendler DL; McClung MR; Miller PD; Olszynski WP; Orwoll E; Yuen CK
    Endocr Rev; 2005 Aug; 26(5):688-703. PubMed ID: 15769903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of teriparatide and its clinical efficacy in the treatment of osteoporosis.
    Dobnig H
    Expert Opin Pharmacother; 2004 May; 5(5):1153-62. PubMed ID: 15155114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant myeloma in a patient after treatment for osteoporosis with teriparatide; a rare coincidence.
    Forslund T; Koski AM; Koistinen A; Sikiö A
    Clin Med Case Rep; 2008; 1():119-22. PubMed ID: 24179360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures.
    Choe EY; Song JE; Park KH; Seok H; Lee EJ; Lim SK; Rhee Y
    J Bone Miner Metab; 2012 Sep; 30(5):596-601. PubMed ID: 22105654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The teriparatide in the treatment of severe senile osteoporosis.
    Manuele S; Sorbello L; Puglisi N; Grasso S; La Malfa L; D'Urbino G; Rizzotto M; Strano S; Maugeri D
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():249-58. PubMed ID: 17317460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of teriparatide treatment for severe osteoporosis in patients with Duchenne muscular dystrophy.
    Nasomyont N; Keefe C; Tian C; Hornung L; Khoury J; Tilden JC; Hochwalt P; Jackson E; Rybalsky I; Wong BL; Rutter MM
    Osteoporos Int; 2020 Dec; 31(12):2449-2459. PubMed ID: 32676823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teriparatide in the treatment of osteoporosis.
    Stroup J; Kane MP; Abu-Baker AM
    Am J Health Syst Pharm; 2008 Mar; 65(6):532-9. PubMed ID: 18319498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of teriparatide in osteoporotic fracture patients.
    Collinge C; Favela J
    Injury; 2016 Jan; 47 Suppl 1():S36-8. PubMed ID: 26768289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teriparatide treatment complicated by malignant myeloma.
    Koski AM; Sikiö A; Forslund T
    BMJ Case Rep; 2010 Aug; 2010():. PubMed ID: 22767690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Bisphosphonates Versus Teriparatide in Therapy of the Glucocorticoid-Induced Osteoporosis (GIOP): A Meta-Analysis of Randomized Controlled Trials.
    Dong B; Zhou Y; Wang J; Li C; Fu Z; Huang Y; Wang Y; Xu L
    Horm Metab Res; 2023 Apr; 55(4):236-244. PubMed ID: 36652960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report.
    Catalano A; Vita GL; Russo M; Vita G; Lasco A; Morabito N; Messina S
    Osteoporos Int; 2016 Dec; 27(12):3655-3659. PubMed ID: 27589974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of teriparatide and bisphosphonates on new fractures in postmenopausal women with osteoporosis: A protocol for systematic review and meta-analysis.
    Ouyang Y; Chen S; Wan T; Zheng G; Sun G
    Medicine (Baltimore); 2021 Feb; 100(7):e24839. PubMed ID: 33607854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head-to-head comparisons of bisphosphonates and teriparatide in osteoporosis: a meta-analysis.
    Liu CL; Lee HC; Chen CC; Cho DY
    Clin Invest Med; 2017 Jun; 40(3):E146-E157. PubMed ID: 28653616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and effectiveness of daily teriparatide for osteoporosis in patients with severe stages of chronic kidney disease: post hoc analysis of a postmarketing observational study.
    Nishikawa A; Yoshiki F; Taketsuna M; Kajimoto K; Enomoto H
    Clin Interv Aging; 2016; 11():1653-1659. PubMed ID: 27895472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of teriparatide in sequential and combination therapy of osteoporosis.
    Meier C; Lamy O; Krieg MA; Mellinghoff HU; Felder M; Ferrari S; Rizzoli R
    Swiss Med Wkly; 2014; 144():w13952. PubMed ID: 24896070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.